Indication
Protein C deficiency disease
Protein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C. Read more about Protein C deficiency disease
9 drugs 4 manufacturers
Drugs that treat it
Common Protein C deficiency disease therapies.
CEPROTIN (protein C, human)
CEPROTIN (protein C, human)
CEPROTIN (protein C, human)
CEPROTIN (protein C, human)
CEPROTIN (protein C, human)
CEPROTIN (BLUE BAR) (protein C, human)
CEPROTIN (GREEN BAR) (protein C, human)
CEPROTIN (protein C, human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonProtein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C.
Because activated protein C normally cleaves and inactivates activated factors V and VIII, this deficiency leads to unregulated thrombin generation and a heightened propensity for abnormal clotting.
Clinically, mild forms—frequently seen in heterozygous individuals—predominantly manifest in adulthood as recurrent venous thromboembolism, such as deep vein thrombosis and pulmonary embolism.
In contrast, severe forms in homozygous or compound heterozygous neonates present shortly after birth with life-threatening neonatal purpura fulminans characterized by microvascular thrombosis, widespread tissue necrosis, and disseminated intravascular coagulation.
- nih.gov
Protein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C Protein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C. Because activated protein C normally cleaves and inactivates activated factors V and VIII, this...
- patient.info
Protein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C. Because activated protein C normally cleaves and inactivates activated factors V and VIII, this deficiency leads to unregulated thrombin generation and a heightened propensity for abnormal clotting
- medlineplus.gov
Clinically, mild forms—frequently seen in heterozygous individuals—predominantly manifest in adulthood as recurrent venous thromboembolism, such as deep vein thrombosis and pulmonary embolism In contrast, severe forms in homozygous or compound heterozygous neonates present shortly after birth with life-threatening neonatal purpura fulminans characterized by microvascular thrombosis, widespread tissue necrosis, and disseminated intravascular coagulation
- kglmeridian.com
In contrast, severe forms in homozygous or compound heterozygous neonates present shortly after birth with life-threatening neonatal purpura fulminans characterized by microvascular thrombosis, widespread tissue necrosis, and disseminated intravascular coagulation
Personalize your experience
Follow Protein C deficiency disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.